Evidence map›Paper›PMID 38622320›Full record

ArticleScientific reports2024

Assessing the perioperative outcomes of abdominal drain omission after robot-assisted partial nephrectomy.

Francesco Ditonno, Riccardo Bertolo, Alessandro Veccia, Sonia Costantino, Francesca Montanaro, Francesco Artoni, Alberto Baielli, Michele Boldini, Davide Brusa, Vincenzo De Marco and 6 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 2 countries.

Francesco Ditonno *Department of Urology, Borgo Trento Hospital, University of Verona, Azienda Ospedaliera Universitaria Integrata Verona, AUOI Verona, Piazzale Aristide Stefani 1, 37126, Verona, Italy.
Riccardo Bertolo *Department of Urology, Borgo Trento Hospital, University of Verona, Azienda Ospedaliera Universitaria Integrata Verona, AUOI Verona, Piazzale Aristide Stefani 1, 37126, Verona, Italy. riccardogiuseppe.bertolo@univr.it.ORCID http://orcid.org/0000-0003-0260-4601
Alessandro VecciaDepartment of Urology, Borgo Trento Hospital, University of Verona, Azienda Ospedaliera Universitaria Integrata Verona, AUOI Verona, Piazzale Aristide Stefani 1, 37126, Verona, Italy.
Sonia CostantinoDepartment of Urology, Borgo Trento Hospital, University of Verona, Azienda Ospedaliera Universitaria Integrata Verona, AUOI Verona, Piazzale Aristide Stefani 1, 37126, Verona, Italy.
Francesca MontanaroDepartment of Urology, Borgo Trento Hospital, University of Verona, Azienda Ospedaliera Universitaria Integrata Verona, AUOI Verona, Piazzale Aristide Stefani 1, 37126, Verona, Italy.
Francesco ArtoniDepartment of Urology, Borgo Trento Hospital, University of Verona, Azienda Ospedaliera Universitaria Integrata Verona, AUOI Verona, Piazzale Aristide Stefani 1, 37126, Verona, Italy.
Alberto BaielliDepartment of Urology, Borgo Trento Hospital, University of Verona, Azienda Ospedaliera Universitaria Integrata Verona, AUOI Verona, Piazzale Aristide Stefani 1, 37126, Verona, Italy.
Michele BoldiniDepartment of Urology, Borgo Trento Hospital, University of Verona, Azienda Ospedaliera Universitaria Integrata Verona, AUOI Verona, Piazzale Aristide Stefani 1, 37126, Verona, Italy.
Davide BrusaDepartment of Urology, Borgo Trento Hospital, University of Verona, Azienda Ospedaliera Universitaria Integrata Verona, AUOI Verona, Piazzale Aristide Stefani 1, 37126, Verona, Italy.
Vincenzo De MarcoDepartment of Urology, Borgo Trento Hospital, University of Verona, Azienda Ospedaliera Universitaria Integrata Verona, AUOI Verona, Piazzale Aristide Stefani 1, 37126, Verona, Italy.
Filippo MiglioriniDepartment of Urology, Borgo Trento Hospital, University of Verona, Azienda Ospedaliera Universitaria Integrata Verona, AUOI Verona, Piazzale Aristide Stefani 1, 37126, Verona, Italy.
Antonio Benito PorcaroDepartment of Urology, Borgo Trento Hospital, University of Verona, Azienda Ospedaliera Universitaria Integrata Verona, AUOI Verona, Piazzale Aristide Stefani 1, 37126, Verona, Italy.
Riccardo RizzettoDepartment of Urology, Borgo Trento Hospital, University of Verona, Azienda Ospedaliera Universitaria Integrata Verona, AUOI Verona, Piazzale Aristide Stefani 1, 37126, Verona, Italy.
Maria Angela CerrutoDepartment of Urology, Borgo Trento Hospital, University of Verona, Azienda Ospedaliera Universitaria Integrata Verona, AUOI Verona, Piazzale Aristide Stefani 1, 37126, Verona, Italy.
Riccardo AutorinoDepartment of Urology, Rush University Medical Center, Chicago, IL, USA.
Alessandro AntonelliDepartment of Urology, Borgo Trento Hospital, University of Verona, Azienda Ospedaliera Universitaria Integrata Verona, AUOI Verona, Piazzale Aristide Stefani 1, 37126, Verona, Italy.
University of Verona · ITRush University Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The study aimed to evaluate the impact of abdominal drain placement (vs. omission) on perioperative outcomes of robot-assisted partial nephrectomy (RAPN), focusing on complications, time to canalization, deambulation, and pain management. A prospectively-maintained institutional database was queried to get data of patients who underwent RAPN for renal masses between January 2018 and May 2023 at our Institution. Baseline, surgical, and postoperative data were collected. Retrieved patients were stratified based upon placement of abdominal drain (Y/N). Descriptive analyses comparing the two groups were conducted as appropriate.77 After adjusting for potential confounders, a logistic regression analysis was conducted to evaluate significant predictors of any grade and "major" complications. 342 patients were included: 192 patients in the "drain group" versus 150 patients in the "no-drain" group. Renal masses were larger (p < 0.001) and at higher complexity (RENAL score, p = 0.01), in the drain group. Procedures in the drain group had statistically significantly longer operative time, ischemia time, and higher blood loss (all p-values < 0.001). The urinary collecting system was more likely involved compared to the no-drain group (p = 0.01). At multivariate analysis, abdominal drainage was not a significant predictor of any grade (OR 0.79, 95%CI 0.33-1.87) and major postoperative complications (OR 3.62, 95%CI 0.53-9.68). Patients in the drain group experienced a statistically significantly higher hemoglobin drop (p < 0.01). Moreover, they exhibited statistically significant higher paracetamol consumption (p < 0.001) and need for additional opioids (p = 0.02). In summary, the study results suggest the safety of omitting drain placement and remark on the need for personalized decision-making, which considers patient and procedural factors.

Indexed as

Kidney NeoplasmsRoboticsHumansKidneyNephrectomyPostoperative ComplicationsRetrospective StudiesTreatment OutcomeComplicationsDrainNephrectomyRenal neoplasmRobotic

Identifiers

PMID38622320
PMCPMC11018825
OpenAlexW4394813017

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.